BONSAI OXYGEN CONSERVER OM-812

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2017-09-29 for BONSAI OXYGEN CONSERVER OM-812 manufactured by Inovo Inc.

Event Text Entries

[87859573] The device is used to provide supplemental oxygen to patients with compromised respiratory function. It is not intended nor labeled for use as a life sustaining device. It was stated by the reporter that the patient "passed out" (syncopal episode) while using the conserver and that the conserver was "blowing out on its own" (autopulse). Syncopal episodes are a temporary loss of consciousness and posture, described as "fainting" or "passing out". It is usually related to temporary insufficient blood flow to the brain. It most often occurs when the blood pressure is too low (hypotension) and the heart does not pump a normal supply of oxygen to the brain. Syncope can be caused by neurological disorder, orthostatic hypotension or a side effect of medications. An engineering evaluation of the conserver confirms the initial reporters claim that the unit was autopulsing. The setting of 2 l/min is the most common prescription for home oxygen in the us and this was confirmed by the initial reporter to the patient's prescription. As noted in the follow-up interview of the initial reporter, the bonsai was on setting two (2) in the conserve mode, which produces an average, uniform bolus of 22 ml of oxygen per cycle. The unit was observed to be autopulsing at a rate of 140-150 boluses/minute, which means the device was delivering 140-150 twenty-two milliliter (22 ml) boluses of oxygen per minute. As a result, the volume of oxygen that would be delivered to the patient via the nasal cannula per minute (minute volume) would be 3. 08-3. 3 liters of oxygen (or essentially 3. 08-3. 3 l/min). Although this bolus pattern is intermittent and asynchronous with the patient's breathing pattern, there is significant oxygen flowing through the device over the course of each minute, which is available for inhalation. In fact, the minute volume of oxygen delivered would be greater than the amount delivered by a continuous flow oxygen device at the 2 l/min setting. With the information provided, there is insufficient evidence to determine a causal relationship between the unit and the patient's syncopal episode. Although the device was performing out of specification, the fault mode resulted in a rapid, intermittent but near continuous flow (22 ml every 400 milliseconds) of oxygen being delivered to the patient. Because the unit was providing more than enough oxygen to satisfy the patient's oxygen prescription, there is no evidence to support the patient's temporary loss of consciousness (syncopal episode) was caused by the device.
Patient Sequence No: 1, Text Type: N, H10


[87859574] The initial reporter claimed that the patient came in to the office for a visit and was seated in the waiting room with the unit on. The patient suddenly started slumping and passed out. The paramedics were then called and transported the patient to the hospital. The initial reporter claimed that the unit was defective, blowing out continuous on its own. A follow-up interview with the initial reporter revealed that unit was set to the patient's prescription of 2 liters of oxygen per minute on conserve mode. He also explained the unit was attached to a cylinder and tested by a service technician who discovered the unit was blowing continuously on conserve mode. No information was available or provided regarding the patient's medical background nor the hospital disposition.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1062191-2017-00010
MDR Report Key6905811
Report SourceDISTRIBUTOR
Date Received2017-09-29
Date of Report2017-09-29
Date of Event2017-08-29
Date Mfgr Received2017-08-29
Device Manufacturer Date2016-10-14
Date Added to Maude2017-09-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMARITA BRUST
Manufacturer Street401 LEONARD BLVD NORTH
Manufacturer CityLEHIGH ACRES FL 33971
Manufacturer CountryUS
Manufacturer Postal33971
Manufacturer Phone2396436577
Manufacturer G1INOVO INC
Manufacturer Street401 LEONARD BLVD NORTH
Manufacturer CityLEHIGH ACRES FL 33971
Manufacturer CountryUS
Manufacturer Postal Code33971
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBONSAI OXYGEN CONSERVER
Generic NameOXYGEN CONSERVER
Product CodeNFB
Date Received2017-09-29
Returned To Mfg2017-09-25
Model NumberOM-812
Lot Number16129
OperatorLAY USER/PATIENT
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerINOVO INC
Manufacturer Address401 LEONARD BLVD NORTH LEHIGH ACRES FL 33971 US 33971


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2017-09-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.